MedTrace Logo

Cerebrovascular EveNts in Patients Undergoing TranscathetER Aortic Valve Implantation With Balloon-expandable Valves Versus Self-expandable Valves.

NCT03588247 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2024-04-26

No results posted yet for this study

Summary

The aim of this collaborative analysis is to evaluate stroke rates and mortality in patients undergoing TAVI with the self-expandable MCV prosthesis compared to the balloon-expandable ES valve. In the absence of large randomized controlled trials, we will conduct a large collaborative patient-pooled meta-analysis on 30-day stroke and mortality in patients undergoing primary transfemoral TAVI with either MCV or ES valve.

Conditions

  • Aortic Valve Stenosis

Interventions

PROCEDURE

transcatheter aortic valve implantation

Patients with severe aortic valve stenosis undergo transcatheter aortic valve implantation

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Jan Piek, Prof. · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-06-01
Completion
2023-01-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03588247 on ClinicalTrials.gov